Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers.

J Am Chem Soc 2015 Feb 28;137(5):2056-66. Epub 2015 Jan 28.

Departments of Chemistry, Chemical Engineering, and Materials Science and Engineering, ‡Laboratory for Synthetic-Biologic Interactions, and §Texas A&M Institute for Preclinical Studies, Texas A&M University , College Station, Texas 77842, United States.

Nanomaterials have great potential to offer effective treatment against devastating diseases by providing sustained release of high concentrations of therapeutic agents locally, especially when the route of administration allows for direct access to the diseased tissues. Biodegradable polyphosphoester-based polymeric micelles and shell cross-linked knedel-like nanoparticles (SCKs) have been designed from amphiphilic block-graft terpolymers, PEBP-b-PBYP-g-PEG, which effectively incorporate high concentrations of paclitaxel (PTX). Well-dispersed nanoparticles physically loaded with PTX were prepared, exhibiting desirable physiochemical characteristics. Encapsulation of 10 wt% PTX, into either micelles or SCKs, allowed for aqueous suspension of PTX at concentrations up to 4.8 mg/mL, as compared to <2.0 μg/mL for the aqueous solubility of the drug alone. Drug release studies indicated that PTX released from these nanostructures was defined through a structure-function relationship, whereby the half-life of sustained PTX release was doubled through cross-linking of the micellar structure to form SCKs. In vitro, physically loaded micellar and SCK nanotherapeutics demonstrated IC50 values against osteosarcoma cell lines, known to metastasize to the lungs (CCH-OS-O and SJSA), similar to the pharmaceutical Taxol formulation. Evaluation of these materials in vivo has provided an understanding of the effects of nanoparticle structure-function relationships on intratracheal delivery and related biodistribution and pharmacokinetics. Overall, we have demonstrated the potential of these novel nanotherapeutics toward future sustained release treatments via administration directly to the sites of lung metastases of osteosarcoma.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ja512616sDOI Listing
February 2015
31 Reads
16 Citations
12.113 Impact Factor

Publication Analysis

Top Keywords

high concentrations
8
route administration
4
ptx
4
locally route
4
concentrations paclitaxel
4
administration allows
4
allows direct
4
incorporate high
4
paclitaxel ptx
4
ptx well-dispersed
4
nanoparticles physically
4
release high
4
physically loaded
4
concentrations therapeutic
4
well-dispersed nanoparticles
4
effectively incorporate
4
therapeutic agents
4
agents locally
4
direct access
4
scks designed
4

Similar Publications